BR7408886A - Processo para a detectacao da presenca de proteinas com acao de antigenos ou anticorpos - Google Patents

Processo para a detectacao da presenca de proteinas com acao de antigenos ou anticorpos

Info

Publication number
BR7408886A
BR7408886A BR8886/74A BR888674A BR7408886A BR 7408886 A BR7408886 A BR 7408886A BR 8886/74 A BR8886/74 A BR 8886/74A BR 888674 A BR888674 A BR 888674A BR 7408886 A BR7408886 A BR 7408886A
Authority
BR
Brazil
Prior art keywords
antigens
antibodies
proteins
detecting
action
Prior art date
Application number
BR8886/74A
Other languages
English (en)
Portuguese (pt)
Inventor
I Bronstein
A Kapsalis
Original Assignee
Baxter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Laboratories Inc filed Critical Baxter Laboratories Inc
Publication of BR7408886A publication Critical patent/BR7408886A/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/804Radioisotope, e.g. radioimmunoassay
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/819Multifunctional antigen or antibody
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/82Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
BR8886/74A 1973-10-26 1974-10-24 Processo para a detectacao da presenca de proteinas com acao de antigenos ou anticorpos BR7408886A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/410,066 US3949064A (en) 1973-10-26 1973-10-26 Method of detecting antigens or antibodies

Publications (1)

Publication Number Publication Date
BR7408886A true BR7408886A (pt) 1976-05-04

Family

ID=23623067

Family Applications (1)

Application Number Title Priority Date Filing Date
BR8886/74A BR7408886A (pt) 1973-10-26 1974-10-24 Processo para a detectacao da presenca de proteinas com acao de antigenos ou anticorpos

Country Status (15)

Country Link
US (2) US3949064A (cg-RX-API-DMAC10.html)
JP (1) JPS5762020B2 (cg-RX-API-DMAC10.html)
AU (1) AU476619B2 (cg-RX-API-DMAC10.html)
BE (1) BE820660A (cg-RX-API-DMAC10.html)
BR (1) BR7408886A (cg-RX-API-DMAC10.html)
CA (1) CA1036493A (cg-RX-API-DMAC10.html)
DE (1) DE2450523C3 (cg-RX-API-DMAC10.html)
ES (1) ES431413A1 (cg-RX-API-DMAC10.html)
FR (1) FR2249334B1 (cg-RX-API-DMAC10.html)
GB (1) GB1436934A (cg-RX-API-DMAC10.html)
IL (1) IL45707A (cg-RX-API-DMAC10.html)
LU (1) LU71027A1 (cg-RX-API-DMAC10.html)
NL (1) NL7413552A (cg-RX-API-DMAC10.html)
SE (1) SE7413484L (cg-RX-API-DMAC10.html)
ZA (1) ZA746098B (cg-RX-API-DMAC10.html)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172117A (en) * 1974-05-20 1979-10-23 Biotest-Serum-Institut Gmbh Method for the simultaneous measurement of antigens and their antibodies by solid-phase radioimmunoassay
US4225784A (en) * 1976-06-17 1980-09-30 Smith Kline Instruments, Inc. Covalently bound biological substances to plastic materials and use in radioassay
AT343822B (de) * 1976-08-20 1978-06-26 Immuno Ag Radioimmunologisches verfahren und einrichtung zur bestimmung von antigenen
JPS604422B2 (ja) * 1976-10-07 1985-02-04 持田製薬株式会社 抗原の定量方法
USRE34394E (en) * 1978-01-23 1993-09-28 Baxter Diagnostics Inc. Method and composition for double receptor, specific binding assays
JPS608745B2 (ja) * 1978-02-14 1985-03-05 三洋化成工業株式会社 免疫活性物質−つや消しガラス複合体,その製造法及び該複合体を含有してなる測定試薬
US4242322A (en) * 1978-06-07 1980-12-30 Electro-Nucleonics Laboratories, Inc. Methods and materials for detecting antigens and antibodies
US4393040A (en) * 1981-03-24 1983-07-12 Lopapa Institute, Inc. In-vitro diagnostic method for detection of acetylsalicylic acid ingestion
US4994373A (en) 1983-01-27 1991-02-19 Enzo Biochem, Inc. Method and structures employing chemically-labelled polynucleotide probes
US5242798A (en) * 1983-07-21 1993-09-07 Scripps Clinic And Research Foundation Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same
PH21409A (en) * 1983-07-21 1987-10-15 Scripps Clinic Res Synthetic polypeptides and pharmaceutical composition containing the same
JPH07119760B2 (ja) * 1984-07-24 1995-12-20 コモンウエルス・セ−ラム・ラボラトリ−ズ・コミッション ミモトープを検出または決定する方法
US5182082A (en) * 1991-01-23 1993-01-26 Becton, Dickinson And Company Multiple aliquot device for distributing a liquid solution into a well
US5998220A (en) * 1991-05-29 1999-12-07 Beckman Coulter, Inc. Opposable-element assay devices, kits, and methods employing them
US5877028A (en) * 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
US6168956B1 (en) 1991-05-29 2001-01-02 Beckman Coulter, Inc. Multiple component chromatographic assay device
US5348867A (en) * 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
US5698686A (en) 1994-10-20 1997-12-16 Arch Development Corporation Yeast telomerase compositions
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
US5736343A (en) * 1995-08-18 1998-04-07 Landry; Donald Detection of organic compounds through regulation of antibody-catalyzed reactions
US6689757B1 (en) 1996-02-12 2004-02-10 M.L. Laboratories Plc Methods for vaccination and vaccines therefor
US20020034732A1 (en) * 1997-07-30 2002-03-21 Daniel J. Capon Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6610838B1 (en) 1997-09-10 2003-08-26 Symbicom Aktiebolag P13 antigens from Borrelia
WO2000029008A2 (en) * 1998-11-16 2000-05-25 Board Of Regents, The University Of Texas System Hiv-specific t-cell induction
AU2002211201B2 (en) * 2000-11-02 2007-05-31 The National University Of Singapore aopB Gene, protein, homologs, fragments and variants thereof, and their use for cell surface display
EP2292762A3 (en) 2002-12-20 2012-12-12 Board of Regents, The University of Texas System VMP-like sequences of pathogenic Borrelia species and strains
CN1820020B (zh) * 2003-05-06 2010-04-28 技术持有有限公司 Sars-冠状病毒病毒样颗粒以及应用方法
CA2526690C (en) 2003-05-23 2014-01-14 Board Of Regents The University Of Texas System Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors
AU2007281934B2 (en) 2006-01-18 2012-11-15 University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
KR20090114430A (ko) 2007-02-02 2009-11-03 베일러 리서치 인스티튜트 항원-제시 세포 상에서 발현된 dcir에 대한 항원 표적화에 기초한 백신
TWI422594B (zh) 2007-02-02 2014-01-11 Baylor Res Inst 經由樹狀細胞去唾液酸糖蛋白受體(dc-asgpr)接合抗原呈現細胞之藥劑
JP5543785B2 (ja) * 2007-02-02 2014-07-09 ベイラー リサーチ インスティテュート ヒト化ターゲティングモノクローナル抗体と複合体を形成する複数の可変抗原
EP2129692A4 (en) * 2007-02-23 2010-12-15 Baylor Res Inst ACTIVATION OF CELLS WITH HUMAN ANTIGENES BY CLEC-6
KR20090127886A (ko) 2007-02-23 2009-12-14 베일러 리서치 인스티튜트 수지상 세포 렉틴 유사 산화된 ldl 수용체-1(lox-1)을 통한 사람 항원제시세포의 활성화
NZ624059A (en) * 2007-02-23 2015-10-30 Baylor Res Inst Therapeutic applications of activation of human antigen-presenting cells through dectin-1
US9138470B2 (en) * 2007-11-02 2015-09-22 The Johns Hopkins University Multi-component L2 vaccine for prevention of human papilloma virus infection
RU2539765C2 (ru) * 2008-07-16 2015-01-27 Бейлор Рисёч Инститьют ВИЧ ВАКЦИНА, ОСНОВАННАЯ НА НАПРАВЛЕННОСТИ МАКСИМИЗИРОВАННЫХ Gag И Nef НА ДЕНДРИТНЫЕ КЛЕТКИ
WO2010042481A1 (en) 2008-10-06 2010-04-15 University Of Chicago Compositions and methods related to bacterial eap, emp, and/or adsa proteins
EP2414387B1 (en) 2009-04-03 2015-12-16 University Of Chicago Compositions and methods related to protein a (spa) variants
US10080799B2 (en) 2010-02-12 2018-09-25 Arizona Board Of Regents On Behalf Of Arizona State University Methods and compositions related to glycoprotein-immunoglobulin fusions
JP2013523818A (ja) 2010-04-05 2013-06-17 ザ・ユニバーシティー・オブ・シカゴ 免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法
ES2655701T3 (es) 2010-07-02 2018-02-21 The University Of Chicago Composiciones y métodos relacionados con variantes de la proteína A (SpA)
US9095540B2 (en) 2010-09-09 2015-08-04 The University Of Chicago Methods and compositions involving protective staphylococcal antigens
US9567346B2 (en) 2010-10-29 2017-02-14 Life Technologies Corporation Biotin derivatives
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
EP3805395A1 (en) 2012-04-26 2021-04-14 University Of Chicago Staphylococcal coagulase antigens and methods of their use
EP2900685B1 (en) 2012-09-27 2017-10-25 Research Development Foundation Attenuated chikungunya virus
WO2014138696A1 (en) 2013-03-07 2014-09-12 University Of Maryland, Baltimore Immunotherapeutic potential of modified lipooligosaccharides/lipid a
CA2949081C (en) 2014-05-16 2023-03-07 Baylor Research Institute Methods and compositions for treating autoimmune and inflammatory conditions
US10662226B2 (en) 2016-10-28 2020-05-26 The Regents of the University of Caiifomia Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers
US11413336B2 (en) 2018-03-23 2022-08-16 Board Of Regents, The University Of Texas System Coccidioides antigens and methods of their use
US11548938B2 (en) 2018-08-21 2023-01-10 Quidel Corporation DbpA antibodies and uses thereof
KR20220004985A (ko) 2019-03-27 2022-01-12 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) Cd40 활성화 특성을 가진 재조합 단백질
JP7643730B2 (ja) 2019-05-14 2025-03-11 ザ・ユニバーシティ・オブ・シカゴ ブドウ球菌(Staphylococcus)プロテインA(SpA)変種を含む方法および組成物
KR20220131895A (ko) 2019-11-21 2022-09-29 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 항-pd-1/il-15 면역사이토카인을 이용하여 pd-1을 표적으로 하는 신규한 면역요법
WO2021178637A1 (en) 2020-03-05 2021-09-10 Iowa State University Research Foundation, Inc. IMMUNOGENIC AND VACCINE COMPOSITIONS AGAINST SARS-CoV-2
WO2021228836A1 (en) 2020-05-13 2021-11-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Recombinant proteins with ox40 activating properties
JP2025504887A (ja) 2022-01-28 2025-02-19 ファイザー・インク コロナウイルス抗原バリアント
WO2025017036A1 (en) 2023-07-17 2025-01-23 Institut National de la Santé et de la Recherche Médicale Alphavirus nsp3 helical tubular scaffolds
WO2025027492A1 (en) 2023-07-31 2025-02-06 Pfizer Inc. Coronavirus antigen variants
WO2025257397A1 (en) 2024-06-14 2025-12-18 Institut National de la Santé et de la Recherche Médicale Live attenuated bordetella vaccines capable of producing and secreting heterologous antigens
WO2026022374A1 (en) 2024-07-26 2026-01-29 Institut National de la Santé et de la Recherche Médicale Methods for the prophylactic treatment of chikungunya virus infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE337223B (cg-RX-API-DMAC10.html) * 1967-05-23 1971-08-02 Pharmacia Ab
SE343210B (cg-RX-API-DMAC10.html) * 1967-12-20 1972-03-06 Pharmacia Ab
US3646346A (en) * 1968-12-26 1972-02-29 Pharmacia Ab Antibody-coated tube system for radioimmunoassay
US3867517A (en) * 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies

Also Published As

Publication number Publication date
IL45707A (en) 1977-01-31
DE2450523C3 (de) 1978-06-22
US3949064A (en) 1976-04-06
LU71027A1 (cg-RX-API-DMAC10.html) 1975-04-17
JPS5762020B2 (cg-RX-API-DMAC10.html) 1982-12-27
USRE29955E (en) 1979-04-03
DE2450523A1 (de) 1975-05-22
NL7413552A (nl) 1975-04-29
GB1436934A (en) 1976-05-26
AU476619B2 (en) 1976-09-30
SE7413484L (cg-RX-API-DMAC10.html) 1975-04-28
ZA746098B (en) 1975-11-26
JPS5075095A (cg-RX-API-DMAC10.html) 1975-06-20
AU7378774A (en) 1976-04-01
CA1036493A (en) 1978-08-15
FR2249334A1 (cg-RX-API-DMAC10.html) 1975-05-23
ES431413A1 (es) 1976-10-16
FR2249334B1 (cg-RX-API-DMAC10.html) 1977-03-25
BE820660A (fr) 1975-02-03
IL45707A0 (en) 1974-11-29
DE2450523B2 (de) 1976-10-07

Similar Documents

Publication Publication Date Title
BR7408886A (pt) Processo para a detectacao da presenca de proteinas com acao de antigenos ou anticorpos
BR7409549A (pt) Processo para a preparacao de substancias espumosas
AT331975B (de) Verfahren zur verbesserung der nachweisempfindlichkeit von immunologischen diagnostischen proben
AT326818B (de) Verfahren zur bestimmung des vorliegens von antigenen oder ihrer antikorper
FR2334954A1 (fr) Reactif convenant pour la determination immunologique enzymatique
DK140020B (da) Bærermateriale til uopløseliggørelse af proteiner på basis af en mineralsk bærer indeholdende modificerede hydroxylgrupper samt fremgangsmåde til fremstilling af et sådant bærermateriale.
HU172778B (hu) Sposob i reagent enzimaticheskogo opredelenija koncentracii substrata
SE7512862L (sv) Cementliknande produkt med glasfiberarmering
NL7901536A (nl) Bepaling van antigenen of antilichamen.
IT1023109B (it) Indicatore per saggi clinici e relativo procedimento di produzione
BR7300391D0 (pt) Processo para a preparacao de sulfatos de esterina
BR7404534D0 (pt) Aperfeicoamento no processo para a preparacao da acrilo-nitrila ou da meta-acrilo-nitrila
BR7303669D0 (pt) Processo para a preparacao de tio-carbamil-sulfenamidas
BR7607283A (pt) Produtos de condensacao de triois,tetraois e/ou hexois com compostos de tetrahidro-delta3-benzaldeidos,processo para sua preparacao e sua aplicacao
BR7406086D0 (pt) Processo e aparelho aperfeicoados para detectacao e purificacao de proteinas e anticorpos
BR7301612D0 (pt) Processo para a preparacao de 4-nitroso-difenilaminas
BR7603435A (pt) Processo para a preparacao de 3-fenoxi-benzaldeido opcionalmente substituido ou de um seu acetal
BE801808A (fr) Production de fibres proteiques.
BR7309969D0 (pt) Processo e reagente para analise de creatinguinasse
BR7305145D0 (pt) Processo para a preparacao de um polimero de anticorpos deprocesso para a preparacao de um polimero de anticorpos de uma isoenzima especifica uma isoenzima especifica
BE787014A (fr) Procede et reactif pour deceler la presence de l'antigene australien
BE818797A (fr) Antigene de tetanos
BR7304049D0 (pt) Processo para a preparacao de 3-nitro-4-amino-tolueno
IT1008978B (it) Metodo per pretrattare siero e pro dotto ottenuto
BR7401115D0 (pt) Processo para identificacao de artigos manufaturados